Despite the presence of BRAF mutations in lung tumors for several years, the connection between BRAF mutations and lung cancer remains a subject of debate due to the scarcity of clinical case studies.[16,17] Consequently, we undertook a comprehensive meta-analysis, examining a significant number of pertinent papers, in order to accurately evaluate the correlation between BRAF mutations and NSCLC. The gene discussed is BRAF; the disease is lung carcinoma.